nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—Myoglobin urine present—Rosuvastatin—atherosclerosis	0.131	0.163	CcSEcCtD
Succinylcholine—Myoglobinuria—Rosuvastatin—atherosclerosis	0.131	0.163	CcSEcCtD
Succinylcholine—Myoglobinuria—Pravastatin—atherosclerosis	0.0935	0.117	CcSEcCtD
Succinylcholine—Myoglobin urine present—Pravastatin—atherosclerosis	0.0935	0.117	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.017	0.0212	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Lovastatin—atherosclerosis	0.0144	0.018	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.0141	0.0176	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Simvastatin—atherosclerosis	0.0135	0.0168	CcSEcCtD
Succinylcholine—Hypertonia—Rosuvastatin—atherosclerosis	0.0132	0.0164	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Niacin—atherosclerosis	0.0124	0.0154	CcSEcCtD
Succinylcholine—Rhabdomyolysis—Pravastatin—atherosclerosis	0.0122	0.0152	CcSEcCtD
Succinylcholine—Renal failure acute—Rosuvastatin—atherosclerosis	0.0118	0.0148	CcSEcCtD
Succinylcholine—Hypertonia—Niacin—atherosclerosis	0.0096	0.012	CcSEcCtD
Succinylcholine—Renal failure acute—Pravastatin—atherosclerosis	0.00848	0.0106	CcSEcCtD
Succinylcholine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00675	0.00842	CcSEcCtD
Succinylcholine—Flushing—Lovastatin—atherosclerosis	0.00594	0.00741	CcSEcCtD
Succinylcholine—Flushing—Ezetimibe—atherosclerosis	0.00583	0.00727	CcSEcCtD
Succinylcholine—Myalgia—Rosuvastatin—atherosclerosis	0.0056	0.00698	CcSEcCtD
Succinylcholine—Flushing—Simvastatin—atherosclerosis	0.00556	0.00693	CcSEcCtD
Succinylcholine—Flushing—Niacin—atherosclerosis	0.0051	0.00636	CcSEcCtD
Succinylcholine—Flushing—Pravastatin—atherosclerosis	0.00502	0.00627	CcSEcCtD
Succinylcholine—Arrhythmia—Niacin—atherosclerosis	0.00491	0.00613	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00489	0.0061	CcSEcCtD
Succinylcholine—Arrhythmia—Pravastatin—atherosclerosis	0.00484	0.00603	CcSEcCtD
Succinylcholine—Myalgia—Lovastatin—atherosclerosis	0.00474	0.00592	CcSEcCtD
Succinylcholine—Hypertension—Ezetimibe—atherosclerosis	0.00472	0.00589	CcSEcCtD
Succinylcholine—Myalgia—Ezetimibe—atherosclerosis	0.00465	0.0058	CcSEcCtD
Succinylcholine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00455	0.00567	CcSEcCtD
Succinylcholine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00446	0.00556	CcSEcCtD
Succinylcholine—Myalgia—Simvastatin—atherosclerosis	0.00444	0.00554	CcSEcCtD
Succinylcholine—Urticaria—Rosuvastatin—atherosclerosis	0.00426	0.00532	CcSEcCtD
Succinylcholine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00425	0.00531	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00414	0.00517	CcSEcCtD
Succinylcholine—Myalgia—Niacin—atherosclerosis	0.00407	0.00508	CcSEcCtD
Succinylcholine—Hypertension—Pravastatin—atherosclerosis	0.00407	0.00508	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00406	0.00507	CcSEcCtD
Succinylcholine—Myalgia—Pravastatin—atherosclerosis	0.00401	0.005	CcSEcCtD
Succinylcholine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00395	0.00493	CcSEcCtD
Succinylcholine—Anaphylactic shock—Niacin—atherosclerosis	0.00391	0.00487	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00388	0.00483	CcSEcCtD
Succinylcholine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00385	0.0048	CcSEcCtD
Succinylcholine—Shock—Niacin—atherosclerosis	0.00384	0.00479	CcSEcCtD
Succinylcholine—Tachycardia—Niacin—atherosclerosis	0.00381	0.00476	CcSEcCtD
Succinylcholine—Hypotension—Niacin—atherosclerosis	0.00365	0.00455	CcSEcCtD
Succinylcholine—Urticaria—Lovastatin—atherosclerosis	0.00361	0.00451	CcSEcCtD
Succinylcholine—Body temperature increased—Lovastatin—atherosclerosis	0.0036	0.00448	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00356	0.00444	CcSEcCtD
Succinylcholine—Urticaria—Ezetimibe—atherosclerosis	0.00354	0.00442	CcSEcCtD
Succinylcholine—Body temperature increased—Ezetimibe—atherosclerosis	0.00353	0.0044	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.0035	0.00437	CcSEcCtD
Succinylcholine—Rash—Rosuvastatin—atherosclerosis	0.00338	0.00422	CcSEcCtD
Succinylcholine—Dermatitis—Rosuvastatin—atherosclerosis	0.00338	0.00422	CcSEcCtD
Succinylcholine—Urticaria—Simvastatin—atherosclerosis	0.00338	0.00422	CcSEcCtD
Succinylcholine—Body temperature increased—Simvastatin—atherosclerosis	0.00336	0.00419	CcSEcCtD
Succinylcholine—Hypersensitivity—Lovastatin—atherosclerosis	0.00335	0.00418	CcSEcCtD
Succinylcholine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00329	0.0041	CcSEcCtD
Succinylcholine—Hypersensitivity—Simvastatin—atherosclerosis	0.00313	0.00391	CcSEcCtD
Succinylcholine—Urticaria—Niacin—atherosclerosis	0.0031	0.00387	CcSEcCtD
Succinylcholine—Body temperature increased—Niacin—atherosclerosis	0.00309	0.00385	CcSEcCtD
Succinylcholine—Urticaria—Pravastatin—atherosclerosis	0.00306	0.00381	CcSEcCtD
Succinylcholine—Body temperature increased—Pravastatin—atherosclerosis	0.00304	0.00379	CcSEcCtD
Succinylcholine—Hypersensitivity—Niacin—atherosclerosis	0.00288	0.00359	CcSEcCtD
Succinylcholine—Rash—Lovastatin—atherosclerosis	0.00287	0.00358	CcSEcCtD
Succinylcholine—Dermatitis—Lovastatin—atherosclerosis	0.00287	0.00357	CcSEcCtD
Succinylcholine—Hypersensitivity—Pravastatin—atherosclerosis	0.00283	0.00353	CcSEcCtD
Succinylcholine—Rash—Ezetimibe—atherosclerosis	0.00281	0.00351	CcSEcCtD
Succinylcholine—Dermatitis—Ezetimibe—atherosclerosis	0.00281	0.00351	CcSEcCtD
Succinylcholine—Rash—Simvastatin—atherosclerosis	0.00268	0.00335	CcSEcCtD
Succinylcholine—Dermatitis—Simvastatin—atherosclerosis	0.00268	0.00334	CcSEcCtD
Succinylcholine—Rash—Niacin—atherosclerosis	0.00246	0.00307	CcSEcCtD
Succinylcholine—Dermatitis—Niacin—atherosclerosis	0.00246	0.00307	CcSEcCtD
Succinylcholine—Rash—Pravastatin—atherosclerosis	0.00243	0.00302	CcSEcCtD
Succinylcholine—Dermatitis—Pravastatin—atherosclerosis	0.00242	0.00302	CcSEcCtD
Succinylcholine—CHRM1—GPCR downstream signaling—CCL5—atherosclerosis	8.04e-05	0.000406	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CCL5—atherosclerosis	8.02e-05	0.000404	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	8e-05	0.000404	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CETP—atherosclerosis	7.95e-05	0.000401	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	7.94e-05	0.0004	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CNR2—atherosclerosis	7.76e-05	0.000391	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR ligand binding—CXCL8—atherosclerosis	7.75e-05	0.000391	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MMP3—atherosclerosis	7.74e-05	0.00039	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CNR2—atherosclerosis	7.73e-05	0.00039	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR ligand binding—CXCL8—atherosclerosis	7.73e-05	0.00039	CbGpPWpGaD
Succinylcholine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	7.72e-05	0.00039	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MMP3—atherosclerosis	7.72e-05	0.000389	CbGpPWpGaD
Succinylcholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	7.7e-05	0.000388	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CNR2—atherosclerosis	7.66e-05	0.000386	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	7.65e-05	0.000386	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PRKCG—atherosclerosis	7.65e-05	0.000386	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	7.64e-05	0.000385	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PRKCG—atherosclerosis	7.62e-05	0.000384	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—SCARB1—atherosclerosis	7.62e-05	0.000384	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	7.55e-05	0.000381	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	7.36e-05	0.000371	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	7.34e-05	0.00037	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	7.31e-05	0.000368	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	7.28e-05	0.000367	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	7.27e-05	0.000367	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	7.21e-05	0.000364	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—HMGCR—atherosclerosis	7.19e-05	0.000363	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—HMOX1—atherosclerosis	7.15e-05	0.000361	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	7.07e-05	0.000357	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	6.95e-05	0.00035	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	6.92e-05	0.000349	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VWF—atherosclerosis	6.92e-05	0.000349	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VWF—atherosclerosis	6.89e-05	0.000348	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOC3—atherosclerosis	6.87e-05	0.000347	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	6.86e-05	0.000346	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOB—atherosclerosis	6.85e-05	0.000346	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOC3—atherosclerosis	6.85e-05	0.000345	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LDLR—atherosclerosis	6.83e-05	0.000344	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VWF—atherosclerosis	6.83e-05	0.000344	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LDLR—atherosclerosis	6.81e-05	0.000343	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOC3—atherosclerosis	6.78e-05	0.000342	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LDLR—atherosclerosis	6.74e-05	0.00034	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	6.73e-05	0.000339	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	6.71e-05	0.000338	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL3—atherosclerosis	6.67e-05	0.000336	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—GSTM1—atherosclerosis	6.66e-05	0.000336	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL3—atherosclerosis	6.65e-05	0.000335	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	6.64e-05	0.000335	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL3—atherosclerosis	6.59e-05	0.000332	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—LPL—atherosclerosis	6.54e-05	0.00033	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ABCA1—atherosclerosis	6.41e-05	0.000323	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NCF1—atherosclerosis	6.39e-05	0.000322	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—GPX1—atherosclerosis	6.38e-05	0.000322	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NCF1—atherosclerosis	6.37e-05	0.000321	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NCF1—atherosclerosis	6.31e-05	0.000318	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—F2—atherosclerosis	6.22e-05	0.000314	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CD36—atherosclerosis	6.22e-05	0.000313	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—F2—atherosclerosis	6.2e-05	0.000313	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—F2—atherosclerosis	6.14e-05	0.00031	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AGT—atherosclerosis	6.11e-05	0.000308	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AGT—atherosclerosis	6.09e-05	0.000307	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	6.03e-05	0.000304	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR2—atherosclerosis	6.03e-05	0.000304	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AGT—atherosclerosis	6.03e-05	0.000304	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR2—atherosclerosis	6.01e-05	0.000303	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	6.01e-05	0.000303	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CYBA—atherosclerosis	6.01e-05	0.000303	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CYBA—atherosclerosis	5.99e-05	0.000302	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR2—atherosclerosis	5.96e-05	0.0003	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	5.96e-05	0.0003	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	5.95e-05	0.0003	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	5.93e-05	0.000299	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CYBA—atherosclerosis	5.93e-05	0.000299	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—MTHFR—atherosclerosis	5.89e-05	0.000297	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PARP1—atherosclerosis	5.88e-05	0.000297	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GHRL—atherosclerosis	5.88e-05	0.000297	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PLAT—atherosclerosis	5.88e-05	0.000297	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	5.87e-05	0.000296	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PLAT—atherosclerosis	5.86e-05	0.000296	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PARP1—atherosclerosis	5.86e-05	0.000296	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GHRL—atherosclerosis	5.86e-05	0.000296	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	5.8e-05	0.000293	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	5.8e-05	0.000293	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	5.8e-05	0.000293	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPARA—atherosclerosis	5.78e-05	0.000291	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—F2—atherosclerosis	5.65e-05	0.000285	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—F2—atherosclerosis	5.63e-05	0.000284	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AGT—atherosclerosis	5.6e-05	0.000282	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—F2—atherosclerosis	5.57e-05	0.000281	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—HMOX1—atherosclerosis	5.5e-05	0.000277	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOE—atherosclerosis	5.48e-05	0.000277	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CAV1—atherosclerosis	5.43e-05	0.000274	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOA1—atherosclerosis	5.42e-05	0.000273	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	5.4e-05	0.000273	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	5.39e-05	0.000272	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	5.33e-05	0.000269	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOB—atherosclerosis	5.27e-05	0.000266	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	5.16e-05	0.00026	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KNG1—atherosclerosis	5.14e-05	0.000259	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	5.13e-05	0.000259	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GSTM1—atherosclerosis	5.13e-05	0.000258	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	5.11e-05	0.000258	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	5.09e-05	0.000257	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	5.06e-05	0.000255	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	5.03e-05	0.000254	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—LPL—atherosclerosis	5.03e-05	0.000254	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	5.02e-05	0.000253	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PLG—atherosclerosis	5e-05	0.000252	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PLG—atherosclerosis	4.98e-05	0.000251	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	4.97e-05	0.000251	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CG—atherosclerosis	4.95e-05	0.00025	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PLG—atherosclerosis	4.94e-05	0.000249	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GPX1—atherosclerosis	4.91e-05	0.000248	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CD36—atherosclerosis	4.78e-05	0.000241	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PPARG—atherosclerosis	4.78e-05	0.000241	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	4.73e-05	0.000239	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	4.72e-05	0.000238	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—INS—atherosclerosis	4.68e-05	0.000236	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	4.67e-05	0.000236	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	4.57e-05	0.000231	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP3—atherosclerosis	4.56e-05	0.00023	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	4.55e-05	0.00023	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF2—atherosclerosis	4.54e-05	0.000229	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—MTHFR—atherosclerosis	4.53e-05	0.000228	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	4.51e-05	0.000228	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	4.49e-05	0.000227	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARA—atherosclerosis	4.44e-05	0.000224	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOB—atherosclerosis	4.42e-05	0.000223	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOB—atherosclerosis	4.41e-05	0.000222	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	4.38e-05	0.000221	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	4.37e-05	0.00022	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOB—atherosclerosis	4.36e-05	0.00022	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	4.35e-05	0.000219	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EDN1—atherosclerosis	4.34e-05	0.000219	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	4.33e-05	0.000218	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	4.32e-05	0.000218	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AGT—atherosclerosis	4.3e-05	0.000217	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL5—atherosclerosis	4.3e-05	0.000217	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ALB—atherosclerosis	4.29e-05	0.000217	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	4.29e-05	0.000217	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	4.26e-05	0.000215	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LPL—atherosclerosis	4.22e-05	0.000213	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOE—atherosclerosis	4.22e-05	0.000213	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LPL—atherosclerosis	4.21e-05	0.000212	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAV1—atherosclerosis	4.18e-05	0.000211	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOA1—atherosclerosis	4.17e-05	0.00021	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LPL—atherosclerosis	4.17e-05	0.00021	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—NOS3—atherosclerosis	4.11e-05	0.000207	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	4.1e-05	0.000207	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	4.09e-05	0.000206	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	4.05e-05	0.000204	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	4e-05	0.000202	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SPP1—atherosclerosis	3.98e-05	0.000201	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	3.98e-05	0.000201	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	3.97e-05	0.0002	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	3.95e-05	0.000199	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	3.93e-05	0.000198	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CG—atherosclerosis	3.81e-05	0.000192	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS2—atherosclerosis	3.76e-05	0.000189	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	3.7e-05	0.000186	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	3.69e-05	0.000186	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARG—atherosclerosis	3.67e-05	0.000185	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	3.65e-05	0.000184	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AGT—atherosclerosis	3.61e-05	0.000182	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—INS—atherosclerosis	3.6e-05	0.000182	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AGT—atherosclerosis	3.6e-05	0.000181	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AGT—atherosclerosis	3.56e-05	0.00018	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LEP—atherosclerosis	3.54e-05	0.000178	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOE—atherosclerosis	3.54e-05	0.000178	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOE—atherosclerosis	3.53e-05	0.000178	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LEP—atherosclerosis	3.53e-05	0.000178	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	3.5e-05	0.000177	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	3.5e-05	0.000176	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CAV1—atherosclerosis	3.49e-05	0.000176	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LEP—atherosclerosis	3.49e-05	0.000176	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOE—atherosclerosis	3.49e-05	0.000176	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOA1—atherosclerosis	3.49e-05	0.000176	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	3.46e-05	0.000174	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	3.45e-05	0.000174	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	3.38e-05	0.00017	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ESR1—atherosclerosis	3.37e-05	0.00017	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—F2—atherosclerosis	3.34e-05	0.000168	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	3.33e-05	0.000168	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—F2—atherosclerosis	3.33e-05	0.000168	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ALB—atherosclerosis	3.3e-05	0.000167	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—F2—atherosclerosis	3.29e-05	0.000166	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	3.19e-05	0.000161	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	3.18e-05	0.00016	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—NOS3—atherosclerosis	3.16e-05	0.000159	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	3.15e-05	0.000159	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	3.06e-05	0.000154	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	3.05e-05	0.000154	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—INS—atherosclerosis	3.02e-05	0.000152	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	3.02e-05	0.000152	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—INS—atherosclerosis	3.01e-05	0.000152	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—INS—atherosclerosis	2.98e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	2.97e-05	0.00015	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL2—atherosclerosis	2.96e-05	0.000149	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	2.93e-05	0.000148	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	2.92e-05	0.000147	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1—atherosclerosis	2.91e-05	0.000147	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS2—atherosclerosis	2.89e-05	0.000146	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	2.89e-05	0.000146	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	2.78e-05	0.00014	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	2.77e-05	0.00014	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	2.74e-05	0.000138	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	2.65e-05	0.000134	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	2.64e-05	0.000133	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	2.62e-05	0.000132	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	2.35e-05	0.000119	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	2.34e-05	0.000118	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	2.32e-05	0.000117	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	2.27e-05	0.000115	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	2.26e-05	0.000114	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	2.24e-05	0.000113	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	2.24e-05	0.000113	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	2.23e-05	0.000112	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	2.21e-05	0.000111	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	2.13e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	2.12e-05	0.000107	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	2.1e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	2.1e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	2.1e-05	0.000106	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	2.08e-05	0.000105	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	2.07e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	2.06e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	2.06e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	2.06e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	2.04e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	2.04e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	1.91e-05	9.63e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	1.9e-05	9.6e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	1.89e-05	9.53e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—atherosclerosis	1.89e-05	9.52e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	1.88e-05	9.5e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	1.88e-05	9.5e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	1.87e-05	9.41e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	1.81e-05	9.11e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	1.8e-05	9.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	1.78e-05	8.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	1.75e-05	8.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	1.75e-05	8.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	1.73e-05	8.72e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—atherosclerosis	1.45e-05	7.32e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—atherosclerosis	1.32e-05	6.66e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—atherosclerosis	1.32e-05	6.64e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—atherosclerosis	1.3e-05	6.57e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	1.22e-05	6.14e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	1.21e-05	6.12e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.2e-05	6.06e-05	CbGpPWpGaD
